SecBot SecBot
8-K ·Filed Apr 17, 2026

TYRA

Tyra Biosciences, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001193125-26-160347
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

The appointment signals board strengthening with a capital markets-savvy executive, potentially positioning for future financings or strategic moves. Monitor for increased engagement from RA Capital or similar investors given Dable's ties.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$35.56
T+0 close · Apr 17, 2026 · via day close
Latest settled
−7.54%
T+60 · $32.88
Vs SPY
−13.68%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 17 $35.56entry
  2. T+1 · 7mo ago −3.35%α −3.15% · $34.37
  3. T+5 · 7mo ago +5.71%α +5.15% · $37.59
  4. T+20 · 6mo ago +2.67%α −2.70% · $36.51
  5. T+60 · 4mo ago −7.54%α −13.68% · $32.88
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Tyra Biosciences appointed Habib J. Dable to its board of directors as a Class II director, effective April 16, 2026. Dable, a seasoned biopharma executive and current advisor at RA Capital, was granted stock options to purchase 44,400 shares. The move expands the board from nine to ten members.

Key Facts

  • Habib J. Dable appointed to the board of directors effective April 16, 2026
  • Board size increased from nine to ten members
  • Dable is a former CEO of Acceleron Pharma and holds board roles at multiple biotech firms
  • Granted options to purchase 44,400 shares of common stock, vesting over 36 months
  • Board determined Dable is independent under Nasdaq rules

Financial Impact

Approximately $1.1 million in initial equity grant (based on 44,400 options at $24.70/share, TYRA's implied price at time of grant)

share dilutioncompensation expense

Risk Factors

  • Limited immediate operational impact from director appointment
  • Equity grant contributes to share dilution

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-160347
Document: 0001193125-26-160347-index-headers.html0001193125-26-160347
Document: 0001193125-26-160347-index.html0001193125-26-160347
Document: 0001193125-26-160347.txt0001193125-26-160347

Track record

13 reports on TYRA

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +20.37% at T+60 after the Jun 26, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 10, 20266d ago 8-K Neutral 4/10 Entry $21.00 Now $19.74 −6.00% settles Nov 17
  2. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $21.75 to $21.53 Now $19.74 −9.24% ▼ −1.03% −0.32% vs SPY
  3. Sep 21, 20268w ago SC 13G Neutral 4/10 Entry $25.57 to $21.98 Now $19.74 −22.80% ▼ −14.04% −12.85% vs SPY
  4. Sep 17, 20268w ago Insider Cluster Bullish 8/10 Entry $25.73 to $21.76 Now $19.74 −23.28% ▼ −15.43% −16.70% vs SPY
  5. Sep 14, 20269w ago S-3ASR Neutral 3/10 Entry $25.07 to $25.65 Now $19.74 −21.26% ▲ +2.31% +2.21% vs SPY
  6. Sep 9, 20269w ago 8-K Bullish 6/10 Entry $22.01 to $24.35 Now $19.74 −10.31% ▲ +10.63% +11.73% vs SPY
  7. Aug 4, 202614w ago 424B5 Bearish 6/10 Entry $25.71 to $25.30 Now $19.74 +23.22% ▲ +1.59% +1.95% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $32.11 to $30.86 Now $19.74 +38.52% ▲ +3.89% +5.28% vs SPY
  9. May 13, 202626w ago 8-K Mixed 5/10 Entry $36.19 to $33.78 Now $19.74 −45.45% ▼ −6.66% −5.50% vs SPY
  10. Apr 20, 202630w ago 3 Neutral 2/10 Entry $36.69 to $35.06 Now $19.74 −46.20% ▼ −4.44% −5.53% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 9h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026